Tag: Next Generation Sequencing (NGS)

By Posted on Posted in Allelic Variant, Genetic Background, Genetic Predisposition, Genetic Susceptibility, Personalized Medicine, Personomics, Pharmacogenetics, Thasso Post, Theragenomic Medicine Tagged with , , , , , , , , , , , , , , , ,

September 18, 2019 – This post is an edited version of parts of a paper that appeared in the Journal of Personalised Medicine (JPM) a week ago und which addresses one of the important topics in connection with the themes of …

Clinical evidence and implementation challenges for pharmacogenomic testing Read more »

By Posted on Posted in Allelic Variant, Companion Test, Diagnostic, Genetic Background, Genetic Predisposition, Genetic Susceptibility, On The Horizon, Personalized Medicine, Pharmacogenetics, Regulatory Announcement, Targeted Therapy, Thasso Post, Theragenomic Medicine Tagged with , , , , , , ,

July 9, 2016 – This is a huge step into the future of theragenomic and personalized medicine and individualized drug safety. In support of the President’s Precision Medicine Initiative (PMI), the American Food & Drug Administration (FDA) just issued two …

Precision Medicine Initiative: draft guidances issued Read more »